Can Essential Oils/Botanical Agents Smart-Nanoformulations Be the Winning Cards against Psoriasis?

Although psoriasis remains one of the most devastating inflammatory disorders due to its huge negative impact on patients’ quality of life, new “green” treatment approaches still need to be fully explored. The purpose of this review article is to focus on the utilization of different essential oils and active constituents of herbal botanical origin for the treatment of psoriasis that proved efficacious via both in vitro and in vivo models. The applications of nanotechnology-based formulations which displayed great potential in augmenting the permeation and delivery of these agents is also addressed. Numerous studies have been found which assessed the potential activity of natural botanical agents to overcome psoriasis. Nano-architecture delivery is applied in order to maximize the benefits of their activity, improve properties, and increase patient compliance. This field of natural innovative formulations can be a promising tool to optimize remediation of psoriasis while minimizing adverse effects.

[1]  F. S. El-Tokhy,et al.  Boosting the In Vivo Transdermal Bioavailability of Asenapine Maleate Using Novel Lavender Oil-Based Lipid Nanocapsules for Management of Schizophrenia , 2023, Pharmaceutics.

[2]  Hend Abd-Allah,et al.  Skin targeting by chitosan/hyaluronate hybrid nanoparticles for the management of irritant contact dermatitis: In vivo therapeutic efficiency in mouse-ear dermatitis model. , 2023, International journal of biological macromolecules.

[3]  L. T. Nguyen,et al.  Signaling pathways and targets of natural products in psoriasis treatment , 2022, Exploration of Medicine.

[4]  M. Abdel-Mottaleb,et al.  Boosting the anti-inflammatory effect of self-assembled hybrid lecithin–chitosan nanoparticles via hybridization with gold nanoparticles for the treatment of psoriasis: elemental mapping and in vivo modeling , 2022, Drug delivery.

[5]  A. J. Shinde,et al.  Herbal Treatment for Management of Psoriasis: An Overview , 2022, Research Journal of Pharmacy and Technology.

[6]  Khalid Rehman Hakeem,et al.  Olive Oil Based Methotrexate Loaded Topical Nanoemulsion Gel for the Treatment of Imiquimod Induced Psoriasis-like Skin Inflammation in an Animal Model , 2021, Biology.

[7]  M. Abdel-Mottaleb,et al.  Self-assembled tacrolimus-loaded lecithin-chitosan hybrid nanoparticles for in vivo management of psoriasis. , 2021, International journal of pharmaceutics.

[8]  M. Abdel-Mottaleb,et al.  Tacrolimus-loaded chitosan nanoparticles for enhanced skin deposition and management of plaque psoriasis. , 2021, Carbohydrate polymers.

[9]  M. Singh,et al.  Polymers in topical delivery of anti-psoriatic medications and other topical agents in overcoming the barriers of conventional treatment strategies , 2021, Progress in Biomaterials.

[10]  N. Krieger,et al.  The Effect of Herbal Medicinal Products on Psoriasis-Like Keratinocytes , 2021, Biomolecules.

[11]  Gautam Singhvi,et al.  Potential herbal constituents for psoriasis treatment as protective and effective therapy , 2020, Phytotherapy research : PTR.

[12]  Juan Luo,et al.  Green Phellodendri Chinensis Cortex-based carbon dots for ameliorating imiquimod-induced psoriasis-like inflammation in mice , 2020, Journal of Nanobiotechnology.

[13]  Tomoya Nakamura,et al.  Eucalyptus oil reduces allergic reactions and suppresses mast cell degranulation by downregulating IgE-FcεRI signalling , 2020, Scientific Reports.

[14]  Yunfei Xie,et al.  The anti-inflammatory potential of Cinnamomum camphora (L.) J.Presl essential oil in vitro and in vivo. , 2020, Journal of ethnopharmacology.

[15]  Ajazuddin,et al.  Statistically optimized calcipotriol fused nanostructured lipid carriers for effectual topical treatment of psoriasis , 2020 .

[16]  M. M. Rizvi,et al.  Novel nanoemulsion gel containing triple natural bio-actives combination of curcumin, thymoquinone, and resveratrol improves psoriasis therapy: in vitro and in vivo studies , 2020, Drug delivery and translational research.

[17]  S. Mohammadi-Samani,et al.  Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages , 2020, Drug design, development and therapy.

[18]  J. Ahmad,et al.  Nanoemulsion loaded polymeric hydrogel for topical delivery of curcumin in psoriasis , 2020 .

[19]  V. K. Rai,et al.  Anti-psoriatic effect of Lavandula angustifolia essential oil and its major components linalool and linalyl acetate. , 2020, Journal of ethnopharmacology.

[20]  J. Ahmad,et al.  Co-Delivery of Imiquimod and Curcumin by Nanoemugel for Improved Topical Delivery and Reduced Psoriasis-Like Skin Lesions , 2020, Biomolecules.

[21]  F. Ahmad,et al.  Nanostructured lipidic carriers for dual drug delivery in the management of psoriasis: Systematic optimization, dermatokinetic and preclinical evaluation , 2020, Journal of Drug Delivery Science and Technology.

[22]  R. Osmani,et al.  Design & development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis , 2020, DARU Journal of Pharmaceutical Sciences.

[23]  S. Baboota,et al.  Trends in nanotechnology-based delivery systems for dermal targeting of drugs: an enticing approach to offset psoriasis , 2020, Expert opinion on drug delivery.

[24]  O. Sammour,et al.  Novel biocompatible essential oil-based lipid nanocapsules with antifungal properties , 2020 .

[25]  A. Martins,et al.  Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs , 2020, Molecular Neurobiology.

[26]  M. Abdel-Mottaleb,et al.  Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis , 2020, Drug delivery.

[27]  K. Raza,et al.  Thymoquinone-loaded lipid vesicles: a promising nanomedicine for psoriasis , 2019, BMC Complementary and Alternative Medicine.

[28]  S. Singh,et al.  Treatment Strategies Against Psoriasis: Principle, Perspectives And Practices. , 2019, Current drug delivery.

[29]  A. Grada,et al.  Nanodermatology‐based solutions for psoriasis: State‐of‐the art and future prospects , 2019, Dermatologic therapy.

[30]  C. Vergara,et al.  Avocado Oil: Characteristics, Properties, and Applications , 2019, Molecules.

[31]  Ebrahim M Yimer,et al.  Nigella sativa L. (Black Cumin): A Promising Natural Remedy for Wide Range of Illnesses , 2019, Evidence-based complementary and alternative medicine : eCAM.

[32]  P. Sharma,et al.  In-Vivo assessment of glucocorticoid loaded tea tree oil nanoemulsion gel , 2019, Journal of Drug Delivery and Therapeutics.

[33]  M. Karimi,et al.  Evaluation of the efficacy of a topical chamomile-pumpkin oleogel for the treatment of plaque psoriasis: an intra-patient, double-blind, randomized clinical trial , 2018, Biomedical Research and Therapy.

[34]  Sanyog Jain,et al.  Active natural oil-based nanoemulsion containing tacrolimus for synergistic antipsoriatic efficacy. , 2018, Nanomedicine.

[35]  P. Sharma,et al.  INHIBITORY EFFECTS ON TUMOR NECROSIS FACTOR ALPHA AND INTERLEUKIN 12 USING CLOBETASOL PROPIONATE LOADED TEA TREE OIL NANOEMULSION GEL ON ANIMAL MODEL , 2018, Asian Journal of Pharmaceutical and Clinical Research.

[36]  U. Wollina,et al.  Is There a Place for Local Natural Treatment of Psoriasis? , 2018, Open access Macedonian journal of medical sciences.

[37]  Thais P. Pivetta,et al.  Development of nanoparticles from natural lipids for topical delivery of thymol: Investigation of its anti-inflammatory properties. , 2018, Colloids and surfaces. B, Biointerfaces.

[38]  A. Morita Current developments in phototherapy for psoriasis , 2018, The Journal of dermatology.

[39]  M. Raghuraman,et al.  In vitro anti-inflammatory and skin protective properties of Virgin coconut oil , 2018, Journal of traditional and complementary medicine.

[40]  E. Okasha,et al.  Effect of Topical Application of Black Seed Oil on Imiquimod‐Induced Psoriasis‐like Lesions in the Thin Skin of Adult Male Albino Rats , 2018, Anatomical record.

[41]  Ying-zheng Zhao,et al.  Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model. , 2017, Colloids and surfaces. B, Biointerfaces.

[42]  Mei X. Wu,et al.  A clinical review of phototherapy for psoriasis , 2017, Lasers in Medical Science.

[43]  Abheepsa Mishra,et al.  Imiquimod‐induced psoriasis‐like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin , 2017, European journal of pharmacology.

[44]  Meriem M. Rezigue,et al.  Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment. , 2017, Current drug metabolism.

[45]  M. Akhtar,et al.  Nonionic surfactant based thymoquinone loaded nanoproniosomal formulation: in vitro physicochemical evaluation and in vivo hepatoprotective efficacy , 2017, Drug development and industrial pharmacy.

[46]  R. Sivamani,et al.  Topical Botanical Agents for the Treatment of Psoriasis: A Systematic Review , 2017, American Journal of Clinical Dermatology.

[47]  S. Gangemi,et al.  Clinical Pharmacology of Citrus bergamia: A Systematic Review , 2017, Phytotherapy research : PTR.

[48]  A. Lamprecht,et al.  In vivo skin penetration of macromolecules in irritant contact dermatitis. , 2016, International journal of pharmaceutics.

[49]  D. Reeves,et al.  Incidence, prevalence and mortality of patients with psoriasis: a U.K. population‐based cohort study , 2016, The British journal of dermatology.

[50]  S. Gangemi,et al.  Anti-Inflammatory Activity of Citrus bergamia Derivatives: Where Do We Stand? , 2016, Molecules.

[51]  A. Herman,et al.  Topically Used Herbal Products for the Treatment of Psoriasis – Mechanism of Action, Drug Delivery, Clinical Studies , 2016, Planta Medica.

[52]  G. Melino,et al.  Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model , 2016, Cell Death and Disease.

[53]  S. Cuzzocrea,et al.  Anti-inflammatory and Antioxidant Effects of Flavonoid-Rich Fraction of Bergamot Juice (BJe) in a Mouse Model of Intestinal Ischemia/Reperfusion Injury , 2016, Front. Pharmacol..

[54]  A. Ogdie,et al.  The Epidemiology of Psoriatic Arthritis. , 2015, Rheumatic diseases clinics of North America.

[55]  A. Michalsen,et al.  A case series of the effects of a novel composition of a traditional natural preparation for the treatment of psoriasis , 2015, Journal of traditional and complementary medicine.

[56]  P. Bramanti,et al.  Effects of bergamot essential oil and its extractive fractions on SH‐SY5Y human neuroblastoma cell growth , 2015, The Journal of pharmacy and pharmacology.

[57]  M. H. Zulfakar,et al.  Probing the effects of fish oil on the delivery and inflammation-inducing potential of imiquimod. , 2015, International journal of pharmaceutics.

[58]  A. Paller,et al.  Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities , 2015, Pediatric Drugs.

[59]  R. Winchester,et al.  Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype , 2015, Arthritis Research & Therapy.

[60]  G. Calapai,et al.  Citrus bergamia essential oil: from basic research to clinical application , 2015, Front. Pharmacol..

[61]  Madhu Gupta,et al.  Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis , 2015, Artificial cells, nanomedicine, and biotechnology.

[62]  V. Zucolotto,et al.  Nanomiemgel - A Novel Drug Delivery System for Topical Application - In Vitro and In Vivo Evaluation , 2014, PloS one.

[63]  Madhu Gupta,et al.  Capsaicin-loaded vesicular systems designed for enhancing localized delivery for psoriasis therapy , 2014, Artificial cells, nanomedicine, and biotechnology.

[64]  A. Lamprecht,et al.  Nanomedicine strategies for targeting skin inflammation. , 2014, Nanomedicine.

[65]  P. Campiglia,et al.  Flavonoid Fraction of Bergamot Juice Reduces LPS-Induced Inflammatory Response through SIRT1-Mediated NF-κB Inhibition in THP-1 Monocytes , 2014, PloS one.

[66]  M. Akhtar,et al.  Neuroprotective study of Nigella sativa-loaded oral provesicular lipid formulation: in vitro and ex vivo study , 2014, Drug delivery.

[67]  S. Arias-Santiago,et al.  Quality of life in persons living with psoriasis patients. , 2014, Journal of the American Academy of Dermatology.

[68]  M. Lebwohl,et al.  Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. , 2014, Journal of the American Academy of Dermatology.

[69]  P. Bryce,et al.  IgE-mediated mast cell responses are inhibited by thymol-mediated, activation-induced cell death in skin inflammation. , 2014, The Journal of allergy and clinical immunology.

[70]  M. Evangelista,et al.  The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate pediatric atopic dermatitis: a randomized, double‐blind, clinical trial , 2014, International journal of dermatology.

[71]  A. Armstrong,et al.  Anti-drug antibodies in psoriasis: a critical evaluation of clinical significance and impact on treatment response , 2013, Expert review of clinical immunology.

[72]  M. Singh,et al.  Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[73]  A. Chaudhuri,et al.  Topical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[74]  Jinhong Hu,et al.  Curcumin Inhibits Imiquimod-Induced Psoriasis-Like Inflammation by Inhibiting IL-1beta and IL-6 Production in Mice , 2013, PloS one.

[75]  Aziz Ahmed,et al.  Omega-3 fatty acids as pharmacotherapeutics in psoriasis: current status and scope of nanomedicine in its effective delivery. , 2013, Current Drug Targets.

[76]  M. Fitó,et al.  Health effects of olive oil polyphenols: recent advances and possibilities for the use of health claims. , 2013, Molecular nutrition & food research.

[77]  R. Clark,et al.  CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17, and IL-22. , 2013, The Journal of investigative dermatology.

[78]  Haihua Feng,et al.  Anti-inflammatory effects of linalool in RAW 264.7 macrophages and lipopolysaccharide-induced lung injury model. , 2013, The Journal of surgical research.

[79]  Rosa Parisi,et al.  Global epidemiology of psoriasis: a systematic review of incidence and prevalence. , 2013, The Journal of investigative dermatology.

[80]  W. Liao,et al.  Phototherapy in Psoriasis: A Review of Mechanisms of Action , 2013, Journal of cutaneous medicine and surgery.

[81]  Sajid Ali,et al.  Topical nanoemulsion of turmeric oil for psoriasis: characterization, ex vivo and in vivo assessment. , 2012 .

[82]  A. Lamprecht,et al.  Surface-charge-dependent nanoparticles accumulation in inflamed skin. , 2012, Journal of pharmaceutical sciences.

[83]  J. Schalkwijk,et al.  Genetics of psoriasis: evidence for epistatic interaction between skin barrier abnormalities and immune deviation. , 2012, The Journal of investigative dermatology.

[84]  L. P. Dwarampudi,et al.  Antipsoriatic activity and cytotoxicity of ethanolic extract of Nigella sativa seeds , 2012, Pharmacognosy magazine.

[85]  A. Lamprecht,et al.  Nanoparticles enhance therapeutic outcome in inflamed skin therapy. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[86]  V. Cardile,et al.  Protective effects of an extract from Citrus bergamia against inflammatory injury in interferon-γ and histamine exposed human keratinocytes. , 2012, Life sciences.

[87]  Jun Yan,et al.  New insights of T cells in the pathogenesis of psoriasis , 2012, Cellular and Molecular Immunology.

[88]  H. Sadeghnia,et al.  Protective effect of Nigella sativa and thymoquinone on serum/glucose deprivation-induced DNA damage in PC12 cells , 2012, Avicenna journal of phytomedicine.

[89]  M. Singhal,et al.  Cassia tora Linn Cream Inhibits Ultraviolet-B-Induced Psoriasis in Rats , 2012, ISRN dermatology.

[90]  Anil Kumar,et al.  Nanoemulsion Based Hydrogel Containing Omega 3 Fatty Acids as a Surrogate of Betamethasone Dipropionate for Topical Delivery , 2012 .

[91]  A. Barton,et al.  Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy , 2012, The British journal of dermatology.

[92]  Dirk Neumann,et al.  Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[93]  Chun-shui Yu Study on HIF-1α Gene Translation in Psoriatic Epidermis with the Topical Treatment of Capsaicin Ointment , 2011, ISRN Pharmaceutics.

[94]  S. Shukla,et al.  Chamomile: an anti-inflammatory agent inhibits inducible nitric oxide synthase expression by blocking RelA/p65 activity. , 2010, International journal of molecular medicine.

[95]  G. Awad,et al.  Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. , 2010, International journal of pharmaceutics.

[96]  R. Baran The Burden of Nail Psoriasis: An Introduction , 2010, Dermatology.

[97]  P. Sarakarn,et al.  A prospective, randomized clinical trial comparing topical aloe vera with 0.1% triamcinolone acetonide in mild to moderate plaque psoriasis , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[98]  Sanjay Gupta,et al.  Chamomile, a novel and selective COX-2 inhibitor with anti-inflammatory activity. , 2009, Life sciences.

[99]  K. Gordon,et al.  Long‐term efficacy of biologics in the treatment of psoriasis: what do we really know? , 2009, Dermatologic therapy.

[100]  Sonke Svenson,et al.  Dendrimers as versatile platform in drug delivery applications. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[101]  V. Verallo-Rowell,et al.  Novel Antibacterial and Emollient Effects of Coconut and Virgin Olive Oils in Adult Atopic Dermatitis , 2008, Dermatitis : contact, atopic, occupational, drug.

[102]  C. Griffiths,et al.  Pathogenesis and clinical features of psoriasis , 2007, The Lancet.

[103]  A. Menter,et al.  Current and future management of psoriasis , 2007, The Lancet.

[104]  D. Sasseville,et al.  Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. , 2007, Journal of the American Academy of Dermatology.

[105]  Charles N. Serhan,et al.  Resolvin E1 and protectin D1 activate inflammation-resolution programmes , 2007, Nature.

[106]  S. Valkova UVB phototherapeutic modalities. Comparison of two treatments for chronic plaque psoriasis. , 2007, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.

[107]  B. J. Villarino,et al.  Descriptive sensory evaluation of virgin coconut oil and refined, bleached and deodorized coconut oil , 2007 .

[108]  James G. Krueger,et al.  Pathogenesis and therapy of psoriasis , 2007, Nature.

[109]  T. Riley,et al.  A review of the toxicity of Melaleuca alternifolia (tea tree) oil. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[110]  M. Atta,et al.  Some characteristics of nigella (Nigella sativa L.) seed cultivated in Egypt and its lipid profile , 2003 .

[111]  N. Lowe,et al.  Current systemic therapies for psoriasis: where are we now? , 2003, Journal of the American Academy of Dermatology.

[112]  N. Chainani-Wu Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). , 2003, Journal of alternative and complementary medicine.

[113]  A. Gurney,et al.  Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17* , 2003, The Journal of Biological Chemistry.

[114]  M. Cork,et al.  Topical preparations for the treatment of psoriasis: a systematic review , 2002, The British journal of dermatology.

[115]  S. Rogers,et al.  Adverse effects with long‐term cyclosporin for severe psoriasis , 2002, Clinical and experimental dermatology.

[116]  J. Hartung,et al.  Vitamin B12 Cream Containing Avocado Oil in the Therapy of Plaque Psoriasis , 2001, Dermatology.

[117]  E. Ernst Adverse effects of herbal drugs in dermatology , 2000, The British journal of dermatology.

[118]  C. Albanesi,et al.  Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. , 2000, The Journal of investigative dermatology.

[119]  B. Escalante,et al.  Antiinflammatory activity of extracts from Aloe vera gel. , 1996, Journal of ethnopharmacology.

[120]  M. GOODFIELD,et al.  Investigations of the ‘active’ edge of plaque psoriasis: vascular proliferation precedes changes in epidermal keratin , 1994, The British journal of dermatology.

[121]  R M Shelton,et al.  Aloe vera , 1991, International journal of dermatology.

[122]  R. D. De Abreu,et al.  Effects of methotrexate on purine and pyrimidine metabolism and cell-kinetic parameters in human malignant lymphoblasts of different lineages. , 1988, Biochemical pharmacology.

[123]  E. Farber,et al.  Stress, symmetry, and psoriasis: possible role of neuropeptides. , 1986, Journal of the American Academy of Dermatology.

[124]  F. Klaschka,et al.  [Comparative testing of Kamillosan cream and steroidal (0.25% hydrocortisone, 0.75% fluocortin butyl ester) and non-steroidal (5% bufexamac) dermatologic agents in maintenance therapy of eczematous diseases]. , 1985, Zeitschrift fur Hautkrankheiten.

[125]  A. C. Cuello,et al.  Capsaicin-induced depletion of substance P from primary sensory neurones , 1978, Brain Research.

[126]  R. Stern Psoriasis , 1903, The Lancet.

[127]  S. Dubey,et al.  Nanocarriers for topical delivery in psoriasis , 2020 .

[128]  I. Akachukwu,et al.  In-silico study of flavonoids from Cassia tora as potential anti-psoriatic agent , 2019, Journal of Applied Pharmaceutical Science.

[129]  G. Duarte,et al.  Revista1Vol90ingles_Layout 1 , 2015 .

[130]  Jawad H. Ahmed,et al.  Evaluation of efficacy, safety and antioxidant effect of Nigella sativa in patients with psoriasis: A randomized clinical trial Psöriazisli hastalarda çörek otunun etkinlik, güvenirlik ve antioksidan etkileri: Randomize bir klinik çalişma , 2014 .

[131]  K. Sonia,et al.  Microemulsion Based Transdermal Drug Delivery of Tea Tree Oil , 2011 .

[132]  A. Wesołowska,et al.  CHEMICAL COMPOSITION OF THE PEPPER FRUIT EXTRACTS OF HOT CULTIVARS Capsicum annuum L. , 2011 .

[133]  J. Lipozenčić,et al.  Drug induced psoriasis. , 2011, Acta dermatovenerologica Croatica : ADC.

[134]  B. Walker,et al.  Rural Industries Research and Development Corporation , 2011 .

[135]  L. Mondello,et al.  Study on the chemical composition variability of some processed bergamot (Citrus bergamia) essential oils , 2010 .

[136]  C. Heard,et al.  Enhanced topical delivery and ex vivo anti-inflammatory activity from a betamethasone dipropionate formulation containing fish oil , 2009, Inflammation Research.

[137]  B. Benjilali,et al.  Seasonal Changes in the Volatile Oil and Cineole Contents of Five Eucalyptus Species Growing in Morocco , 1996 .

[138]  Arya Vaidya Sala Indian medicinal plants : a compendium of 500 species , 1994 .